Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

1HZM

STRUCTURE OF ERK2 BINDING DOMAIN OF MAPK PHOSPHATASE MKP-3: STRUCTURAL INSIGHTS INTO MKP-3 ACTIVATION BY ERK2

Summary for 1HZM
Entry DOI10.2210/pdb1hzm/pdb
DescriptorDUAL SPECIFICITY PROTEIN PHOSPHATASE 6 (1 entity in total)
Functional Keywordshydrolase
Biological sourceHomo sapiens (human)
Cellular locationCytoplasm: Q16828
Total number of polymer chains1
Total formula weight17424.75
Authors
Farooq, A.,Zhou, M.-M. (deposition date: 2001-01-25, release date: 2002-01-25, Last modification date: 2024-05-22)
Primary citationFarooq, A.,Chaturvedi, G.,Mujtaba, S.,Plotnikova, O.,Zeng, L.,Dhalluin, C.,Ashton, R.,Zhou, M.M.
Solution structure of ERK2 binding domain of MAPK phosphatase MKP-3: structural insights into MKP-3 activation by ERK2.
Mol.Cell, 7:387-399, 2001
Cited by
PubMed Abstract: MAP kinases (MAPKs), which control mitogenic signal transduction in all eukaryotic organisms, are inactivated by dual specificity MAPK phosphatases (MKPs). MKP-3, a prototypical MKP, achieves substrate specificity through its N-terminal domain binding to the MAPK ERK2, resulting in the activation of its C-terminal phosphatase domain. The solution structure and biochemical analysis of the ERK2 binding (EB) domain of MKP-3 show that regions that are essential for ERK2 binding partly overlap with its sites that interact with the C-terminal catalytic domain, and that these interactions are functionally coupled to the active site residues of MKP-3. Our findings suggest a novel mechanism by which the EB domain binding to ERK2 is transduced to cause a conformational change of the C-terminal catalytic domain, resulting in the enzymatic activation of MKP-3.
PubMed: 11239467
DOI: 10.1016/S1097-2765(01)00186-1
PDB entries with the same primary citation
Experimental method
SOLUTION NMR
Structure validation

247536

PDB entries from 2026-01-14

PDB statisticsPDBj update infoContact PDBjnumon